Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119831432 | 11983143 | 2 | F | 20160923 | 20160201 | 20160928 | EXP | VE-GLAXOSMITHKLINE-VE2016GSK013285 | GLAXOSMITHKLINE | 0.00 | F | Y | 80.00000 | KG | 20160928 | CN | VE | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119831432 | 11983143 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | Y | U | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
| 119831432 | 11983143 | 2 | SS | Salbutan | ALBUTEROL SULFATE | 1 | 100 MCG | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119831432 | 11983143 | 1 | Asthma |
| 119831432 | 11983143 | 2 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119831432 | 11983143 | HO |
| 119831432 | 11983143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119831432 | 11983143 | Asthmatic crisis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119831432 | 11983143 | 1 | 20151018 | 0 |